RAD Price sensitive 17 Nov 2025, 8:28 AM

RAD Announces 50% Enrollment in Phase 2b Trial of RAD101

Radiopharm Theranostics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in